BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6): 104-113 [PMID: 34904048 DOI: 10.4331/wjbc.v12.i6.104]
URL: https://www.wjgnet.com/1948-5182/full/v12/i6/104.htm
Number Citing Articles
Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's diseaseEuropean Journal of Pharmacology 2023; 939: 175426 doi: 10.1016/j.ejphar.2022.175426
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Ai Tsuji, Satoru Matsuda. A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative DisordersMetabolites 2022; 12(11): 1052 doi: 10.3390/metabo12111052
Oytun Erbas, İlknur Altuntaş, Pemra Nesil, Hadi Sasani, Mehtap Odabaşı. Translational Neuroprotection - The Way Ahead [Working Title]2023;  doi: 10.5772/intechopen.109967
Toshiyuki Murai, Satoru Matsuda. The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological DiseasesMolecules 2023; 28(5): 2381 doi: 10.3390/molecules28052381
Hans-Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, Johann Steiner. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overviewReviews in the Neurosciences 2023; 34(1): 1 doi: 10.1515/revneuro-2022-0026
Nassima Oumata, Kui Lu, Yuou Teng, Christian Cavé, Yu Peng, Hervé Galons, Bernard P. Roques. Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic moleculesEuropean Journal of Medicinal Chemistry 2022; 240: 114578 doi: 10.1016/j.ejmech.2022.114578